For many applications, the Australian Pesticides and Veterinary Medicines Authority (APVMA) is required to publish a summary of the application once the applicant has been notified that the application has been accepted for assessment. The summary will be removed once the application is finalised.
The types of applications requiring an application summary include those for new active constituents, products and labels and applications involving variation to products and labels, where the variation involves a change in the use, supply or disposal of the product.
The summaries include details of the applications as specified in Divisions 2.1 and 2.2 of the regulations.
Please remember to follow the guidance for preparing information lists when preparing your application to avoid sensitive information being published.
For more information, please see the questions and answers.
Use the filter and links below to find and view application summaries.
Date
Application Date
Application No
Application Number
154334
Product/Active constituent Name
Application Product Name
ACCENSI TRI-MAX 480 EC HERBICIDE C
Application Date
Application Number
154334
Application Product Name
ACCENSI TRI-MAX 480 EC HERBICIDE C
Application details
Product name:
ACCENSI TRI-MAX 480 EC HERBICIDE C
Applicant Name:
AUSTRALIAN AGRIBUSINESS (HOLDINGS) PTY LTD
Application purpose and description of use:
Registration of a 480 g/L Trifluralin and 538 g/L Liquid Hydrocarbon EC product for pre-emergence herbicide control of annual grasses and certain broadleaf weeds in certain horticultural and agricultural crops as listed in the Directions for Use table.
Date
Application Date
Application No
Application Number
154335
Product/Active constituent Name
Application Product Name
ACCENSI TRI-MAX 480 EC HERBICIDE D
Application Date
Application Number
154335
Application Product Name
ACCENSI TRI-MAX 480 EC HERBICIDE D
Application details
Product name:
ACCENSI TRI-MAX 480 EC HERBICIDE D
Applicant Name:
AUSTRALIAN AGRIBUSINESS (HOLDINGS) PTY LTD
Application purpose and description of use:
Registration of a 480 g/L Trifluralin and 500 g/L Liquid Hydrocarbons EC product for pre-emergence herbicide for the control of annual grasses and certain broadleaf weeds in certain horticultural and agricultural crops as listed in the Directions for Use table.
Date
Application Date
Application No
Application Number
154389
Product/Active constituent Name
Application Product Name
Accensi Carbendazim 500 SC Fungicide
Application Date
Application Number
154389
Application Product Name
Accensi Carbendazim 500 SC Fungicide
Application details
Product name:
Accensi Carbendazim 500 SC Fungicide
Applicant Name:
AUSTRALIAN AGRIBUSINESS (HOLDINGS) PTY LTD
Application purpose and description of use:
Registration of a 500 g/L Carbendazim suspension concentrate product for a broad spectrum, system fungicide for the control of fungal disease in various crops as indicated in the directions for use table.
Date
Application Date
Application No
Application Number
154390
Product/Active constituent Name
Application Product Name
Accensi Carbendazim 500 SC Fungicide B
Application Date
Application Number
154390
Application Product Name
Accensi Carbendazim 500 SC Fungicide B
Application details
Product name:
Accensi Carbendazim 500 SC Fungicide B
Applicant Name:
AUSTRALIAN AGRIBUSINESS (HOLDINGS) PTY LTD
Application purpose and description of use:
Registration of a 500 g/L Carbendazim suspension concentrate for a broad spectrum, systemic fungicide for the control of fungal diseases in various crops as indicated in the directions for use table.
Date
Application Date
Application No
Application Number
154391
Product/Active constituent Name
Application Product Name
Barmac Glyphosate 540 Herbicide
Application Date
Application Number
154391
Application Product Name
Barmac Glyphosate 540 Herbicide
Application details
Product name:
Barmac Glyphosate 540 Herbicide
Applicant Name:
AUSTRALIAN AGRIBUSINESS (HOLDINGS) PTY LTD
Application purpose and description of use:
Registration of a 540 g/L Glyphosate present as the Potassium Salt soluble concentrate product for non selective control of many annual and perennial weeds as per the Directions for Use.
Date
Application Date
Application No
Application Number
154413
Product/Active constituent Name
Application Product Name
Barmac Glyphosate 540 Herbicide B
Application Date
Application Number
154413
Application Product Name
Barmac Glyphosate 540 Herbicide B
Application details
Product name:
Barmac Glyphosate 540 Herbicide B
Applicant Name:
AUSTRALIAN AGRIBUSINESS (HOLDINGS) PTY LTD
Application purpose and description of use:
Registration of a 540 g/L Glyphosate soluble concentrate product for non-selective control of many annual and perennial weeds.
Date
Application Date
Application No
Application Number
154557
Product/Active constituent Name
Application Product Name
FARMALINX ETHON 720 GROWTH REGULATOR
Application Date
Application Number
154557
Application Product Name
FARMALINX ETHON 720 GROWTH REGULATOR
Application details
Product name:
FARMALINX ETHON 720 GROWTH REGULATOR
Applicant Name:
FARMALINX PTY LTD
Application purpose and description of use:
Registration of a 720 g/L ethephon Soluble concentrate SL product for crop thinning, loosening or ripening in various crops and for accelerating boll opening, defoliation and pre-conditioning before defoliation of cotton
Date
Application Date
Application No
Application Number
154566
Product/Active constituent Name
Application Product Name
Kusabi Fungicide
Application Date
Application Number
154566
Application Product Name
Kusabi Fungicide
Application details
Product name:
Kusabi Fungicide
Applicant Name:
ISHIHARA SANGYO KAISHA, LTD
Application purpose and description of use:
Registration of a 300 g/L Pyriofenone suspension concentrate (SC) product for the control of powdery mildew
in cucurbits and grapes as specified in the Directions for Use Table
Date
Application Date
Application No
Application Number
154508
Product/Active constituent Name
Application Product Name
SEEKER Duo Fungicide
Application Date
Application Number
154508
Application Product Name
SEEKER Duo Fungicide
Application details
Product name:
SEEKER Duo Fungicide
Applicant Name:
SYNGENTA AUSTRALIA PTY LTD
Application purpose and description of use:
Registration of a 475 g/L emulsifiable concentrate product for control of powdery mildew in wine grapes
Date
Application Date
Application No
Application Number
153050
Product/Active constituent Name
Application Product Name
CLAVOX M BROAD SPECTRUM ANTIBIOTIC TABLETS
Application Date
Application Number
153050
Application Product Name
CLAVOX M BROAD SPECTRUM ANTIBIOTIC TABLETS
Application details
Product name:
CLAVOX M BROAD SPECTRUM ANTIBIOTIC TABLETS
Product number:
90686
Applicant Name:
ABBEY LABORATORIES PTY LTD
Application purpose and description of use:
The purpose of this application is to do the variation to the registered product CLAVOX M BROAD SPECTRUM
ANTIBIOTIC TABLETS.
Active constituents:
Active constituent name
84057 - AMOXICILLIN TRIHYDRATE
Active constituent name
91895 - Clavulanate Potassium-Microcrystalline cellulose (1:1)
Description of data provided:
Data no
304236
Title
Executive summary
Study date
2026
Auth party contact address
Unit 27 1 Maitland Place Norwest Australia
Data no
304237
Title
Permit
Study date
2023
Auth party contact address
Unit 27 1 Maitland Place Norwest Australia
Data no
304235
Title
product specifications
Study date
2026
Auth party contact address
Unit 27 1 Maitland Place Norwest Australia
Date
Application Date
Application No
Application Number
153558
Product/Active constituent Name
Application Product Name
Nobivac LoVo Lepto 4 Inactivated Vaccine
Application Date
Application Number
153558
Application Product Name
Nobivac LoVo Lepto 4 Inactivated Vaccine
Application details
Product name:
Nobivac LoVo Lepto 4 Inactivated Vaccine
Product number:
97638
Applicant Name:
INTERVET AUSTRALIA PTY LIMITED
Application purpose and description of use:
Registration of a tetravalent Leptospira injectable vaccine - Nobivac LoVo Lepto 4 Inactivated Vaccine (suspension for injection) product for (proposed use in dogs), in conjunction with approval of (L. Icterohaemorrhagiae, L. Australis, L. Canicola and L. Grippotyphosa) active constituents.
Active constituents:
Active constituent name
92083 - Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001)
Active constituent name
92085 - Leptospira interrogans serogroup Australis serovar Bratislava (strain As-05-073)
Active constituent name
97642 - Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Active constituent name
97643 - Leptospira interrogans serogroup Canicola serovar Portlandvere (strain Ca-12-000)
Description of data provided:
Data no
305945
Title
Part 2
Study date
03 Jun 2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
305946
Title
Part 8
Study date
03 Jun 2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Date
Application Date
Application No
Application Number
153566
Product/Active constituent Name
Application Product Name
Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Application Date
Application Number
153566
Application Product Name
Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Application details
Product name:
Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Product number:
97642
Applicant Name:
INTERVET AUSTRALIA PTY LIMITED
Application purpose and description of use:
New source of active constituent.
Date
Application Date
Application No
Application Number
153567
Product/Active constituent Name
Application Product Name
Leptospira interrogans serogroup Canicola serovar Portlandvere (strain Ca-12-000)
Application Date
Application Number
153567
Application Product Name
Leptospira interrogans serogroup Canicola serovar Portlandvere (strain Ca-12-000)
Application details
Product name:
Leptospira interrogans serogroup Canicola serovar Portlandvere (strain Ca-12-000)
Product number:
97643
Applicant Name:
INTERVET AUSTRALIA PTY LIMITED
Application purpose and description of use:
New source of active constituent.
Date
Application Date
Application No
Application Number
153575
Product/Active constituent Name
Application Product Name
Nobivac Lepto 4 Inactivated Vaccine
Application Date
Application Number
153575
Application Product Name
Nobivac Lepto 4 Inactivated Vaccine
Application details
Product name:
Nobivac Lepto 4 Inactivated Vaccine
Product number:
97644
Applicant Name:
INTERVET AUSTRALIA PTY LIMITED
Application purpose and description of use:
Registration of a tetravalent Leptospira injectable vaccine - Nobivac Lepto 4 Inactivated Vaccine (suspension for injection) product for (proposed use in dogs), in conjunction with approval of (L. Icterohaemorrhagiae, L. Australis, L. Canicola and L. Grippotyphosa) active constituents.
Active constituents:
Active constituent name
92083 - Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001)
Active constituent name
92085 - Leptospira interrogans serogroup Australis serovar Bratislava (strain As-05-073)
Active constituent name
97643 - Leptospira interrogans serogroup Canicola serovar Portlandvere (strain Ca-12-000)
Active constituent name
97642 - Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Description of data provided:
Data no
306073
Title
08R/0241-01: Inactivation study
Study date
28-Sep-2010
Data no
306074
Title
17R/0157: Inactivation fed-batch culture
Study date
07-Aug-2017
Data no
306075
Title
17R/0158: Validation of inactivation
Study date
07-Aug-2017
Data no
306076
Title
17R/0267: Kinetic of inactivation study
Study date
21-Dec-2017
Data no
306077
Title
17R/0268: Kinetic of inactivation study 2
Study date
21-Dec-2017
Data no
306078
Title
13R/0103: Kinetic of inactivation study 3
Study date
31-May-2013
Data no
306079
Title
13R/0104: Kinectic of inactivation study 4
Study date
31-May-2013
Data no
306082
Title
07R/0145: Passive protection in hamsters
Study date
11-Jul-2007
Data no
306083
Title
07R/0108: Passive proetction in hamster study 2
Study date
15-May-2007
Data no
306086
Title
11R/0376: Neutralising antigens
Study date
23-Dec-2011
Data no
306096
Title
06R/0061: Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306097
Title
06R/0040: Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306098
Title
06R/0319: Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306099
Title
06R/0308: Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306101
Title
18R/0129: Validation of sterility
Study date
12-Apr-2018
Data no
306105
Title
04R/0187: Kinetic of inactivation
Study date
22-Sep-2004
Data no
306106
Title
08R/0240: Validation of kinetic inactivation
Study date
28-Sep-2010
Data no
306124
Title
10R/0251 (LEP 08.13.027): Efficacy study
Study date
05-Sep-2010
Data no
306125
Title
11R/0349 (LEP 11.13.045): Efficacy - Assessment of antigens
Study date
22-Dec-2011
Data no
306126
Title
06R/0040 (LEP 04.13.005): Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306128
Title
06R/0319 (LEP 05.13.023): Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306129
Title
06R/0311 (LEP 04.13.014): Duration of immunity study
Study date
14-Dec-2011
Data no
306132
Title
06R/0061 (LEP 04.13.007): Dose-response and onset of immunity
Study date
14-Dec-2011
Data no
306134
Title
06R/0309 (LEP 04.13.003): Duration of immunity
Study date
22-Dec-2011
Data no
306136
Title
10R/0251 (LEP 08.13.027, LEP 10.13.021): Close relatedness of serogroup
Study date
11-Oct-2010
Data no
306138
Title
08R/0075 (LEP 07.13.023): Passive immunisation
Study date
22-04-2010
Data no
306139
Title
11R/0376 (LEP 11.13.050): Detection and quantification of neutralising agent
Study date
23-Dec-2011
Data no
306140
Title
06R/0308 (LEP 04.13.006): Dose-response and onset of immunity
Study date
22-Dec-2011
Data no
306142
Title
06R/0312 (LEP 04.13.011): Duration of immunity
Study date
22-Dec-2011
Data no
306143
Title
07R/0278 (LEP 06.13.010): Efficacy study
Study date
22-Dec-2011
Data no
306144
Title
07R/0330 (LEP 06.13.013): Efficacy study
Study date
22-Dec-2011
Data no
306145
Title
07R/0302 (LEP 06.13.011): Efficacy study
Study date
22-Dec-2011
Data no
306146
Title
07R/0321 (LEP 06.13.012): Efficacy study
Study date
22-Dec-2011
Data no
306147
Title
11R/0346 (LEP 11.13.027): Assessment of protection of antigens
Study date
23-Dec-2011
Data no
306150
Title
08R/0217 (LEP 07.98.1103): Safety and effiacacy trial
Study date
04-Oct-2010
Data no
306151
Title
14R/0175 (LEP 13.98.1192): Safety clinical trial study
Study date
22-Aug-2014
Data no
306152
Title
10R/0130 (LEP 09.03.020/09.13.037): Passive immunisation study
Study date
22-Apr-2010
Data no
306153
Title
07R/0337 (LEP 06.13.016/LEP 06.13.017): Re-vacciation study
Study date
30-Sep-2010
Data no
306156
Title
06R/0249 (LEP 05.13.008): Safety study
Study date
21-12-2006
Data no
306171
Title
07R/0337 (LEP 06.13.016/LEP06.13.017): Passive protection on hamsters
Study date
30-Sep-2010
Data no
306173
Title
06R/0045 (LEP 04.13.003): Duration of immunity
Study date
14-Dec-2011
Data no
306174
Title
11R/0376 (LEP 11.13.050): Detection and quantification of neutralising antigens
Study date
22-Dec-2011
Data no
306091
Title
SOP TI-5139-0005: Preparation of internal standards
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306068
Title
SOP TI-5139-0006: Replacement of materials and reagents
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306137
Title
LE7 21-48-016 (152199): Duration of immunity
Study date
03-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306114
Title
Rare urban-acquired human leptospirosis and environmental health investigation in Sydney, Australia
Study date
19-Feb-2025
Auth party contact address
-
Data no
306045
Title
Glass vial specification
Study date
18-Nov-2015
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306085
Title
06R/0265-02: Validation of antigens study 2
Study date
26-Jul-2012
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306177
Title
Expert report_Safety
Study date
03-Dec-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306131
Title
LE7 23-48-030 (189515): Duration of immunity study
Study date
31-Oct-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306031
Title
Control of canine leptospirosis in Europe: time for a change?
Study date
16-Oct-2010
Auth party contact address
-
Data no
306054
Title
Starting material monographs
Study date
2021
Auth party contact address
-
Data no
306148
Title
Nobivac L4 and Nobivac LoVo L4 SPCs
Study date
28-May-2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306168
Title
S14351-00-ERP-OTH-CN: Safety of inactivated Bb
Study date
15-Feb-2019
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306062
Title
Canicola active constituent
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306111
Title
Leptospira and Leptospirosis
Study date
1994
Auth party contact address
-
Data no
306154
Title
S23265-00: Safty and efficacy clinical study
Study date
28-Oct-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306160
Title
LE7 21-48-015 (143932): Duration of immunity study
Study date
05-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306042
Title
CoA Glass vial 3 mL
Study date
11-Sep-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306065
Title
CoA raw material
Study date
2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306094
Title
SOP TI-5089-0001: Sterility test method 2
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306117
Title
Draft import permit
Study date
25-Mar-2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306048
Title
Raw material specification
Study date
23-Apr-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306071
Title
SOP TI-5117-0003: Testing for presence/absence of antigens
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306180
Title
PAA Written Assistance-150691
Study date
26-May-2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306088
Title
SOP TI-4066-0024: pH measurement
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306034
Title
Canine Leptospirosis serological survey
Study date
7-Nov-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306051
Title
Occupancy and mechanism in antibody-mediated neutralization of animal viruses
Study date
08-May-2002
Auth party contact address
-
Data no
306108
Title
The Spirochaetes: a different way of life
Study date
1995
Auth party contact address
-
Data no
306157
Title
97R/0527 (IDR, 9611): Safety study in pregnant bitches
Study date
10-Oct-1997
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306043
Title
CoA Glass vial 3 mL
Study date
15-Mar-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306066
Title
SOP TI-4066-0830: Detection of antigens
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306089
Title
SOP TI-4066-0835: Osmolality
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306166
Title
06017E/0031/16: Efficacy of inactivated Bb
Study date
12-Feb-2019
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306072
Title
01/2017:0447 and 04/2026:0062
Study date
2017
Auth party contact address
-
Data no
306120
Title
Proposed draft elabels
Study date
28-May-2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306037
Title
Draft import permit
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306183
Title
Nobivac Lepto 4 Part 2 Chemistry (S_0846_2)
Study date
03 Jun 2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306103
Title
COEM-24045: Validation of sterility
Study date
08-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306080
Title
Inactivant
Study date
1988
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306123
Title
Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses
Study date
Sep-2010
Auth party contact address
-
Data no
306172
Title
LEP 18-48-041 (159178): Efficacy of antigen
Study date
04-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306109
Title
A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs
Study date
2012
Auth party contact address
-
Data no
306060
Title
9 CFR:113.27
Study date
1991
Auth party contact address
-
Data no
306092
Title
SOP TI-4066-0830: Determination of antigens
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306163
Title
Memo 193281: Safety studies
Study date
19-Sep-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306069
Title
SOP TI-5089-0001: Sterility testing
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306046
Title
3.2.9.
Study date
2023
Auth party contact address
-
Data no
306040
Title
GMP Certificate
Study date
22-Jan-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
305986
Title
Part 2
Study date
03 Jun 2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306149
Title
15R/0169 (LEP 15.13.006): Safety and efficacy study
Study date
13-May-2016
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306175
Title
LE7 21-48-005: Onset of immunity study
Study date
15-May-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306100
Title
Batch protocol 0431316.1
Study date
Mar-2004
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306169
Title
PSUR Nobivac L4/Lepto 6
Study date
16-Mar-2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306049
Title
08R/0236: Inactivation study
Study date
26-Sep-2008
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306063
Title
New Leptospiral serotypes (serovars) from the Western Hemisphere isolated during 1964 through 1970
Study date
1982
Auth party contact address
-
Data no
306112
Title
Canine Leptospirosis
Study date
Nov-1996
Auth party contact address
-
Data no
306057
Title
CoA of rubber stopper
Study date
02-May-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306155
Title
S22210-00: Safety and efficacy clinical study
Study date
09-Oct-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306164
Title
LE7 21-48-015 (143932): Duration of immunity study
Study date
05-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306041
Title
3.2.1 and 5.1.1.
Study date
2019
Auth party contact address
-
Data no
306118
Title
Expert report_Quality
Study date
04-Dec-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306141
Title
LEP 17-48-007 (159156): Dose-response and onset of immunity
Study date
08-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306095
Title
SOP TI-4066-0277: Physical/chemical investigation
Study date
21-Aug-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306087
Title
ARML_CEPs of raw material
Study date
Nov-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306035
Title
A Scientific Review of Leptospirosis and Implications for Quarantine Policy
Study date
2000
Auth party contact address
-
Data no
306135
Title
LE7 21-48-003 (158491): Onset of immunity
Study date
05-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306081
Title
Investigations of the use of beta-propiolactone in virus inactivation
Study date
1960
Auth party contact address
-
Data no
306181
Title
s8F(1) 92083/134469, 92085/134472, 92084/134470
Study date
12-Oct-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306127
Title
LEP 17-48-006 (159674): Efficacy study
Study date
08-Jul-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306170
Title
LLP 24-48-040 (173566): Safety study
Study date
06-Feb-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306052
Title
08R/0197: Gamma irradiation study
Study date
06-10-2008
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306064
Title
Grippotyphosa active constituent
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306158
Title
S15358-00: Safety clinical study
Study date
04-Apr-2018
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306058
Title
Specs_004580_rubber stopper_13mm
Study date
19-Sep-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306107
Title
s8F(1) 92085/134472
Study date
12-Oct-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306044
Title
Glass vial specification
Study date
23-Feb-2015
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306115
Title
A scientific review of leptospirosis and implications for quarantine policy
Study date
2000
Auth party contact address
-
Data no
306161
Title
LE7 21-48-017 (154647): Duration of immunity study
Study date
27-Jun-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306167
Title
S16037-00-ERP-OTH-CN: Efficacy study of inactivated Bb
Study date
13-Feb-2019
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306038
Title
Proposed eLabels
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306121
Title
Vaccine for veterinary use
Study date
2026
Auth party contact address
-
Data no
306178
Title
Cross-sectional study of canine leptospirosis in animal shelter populations in mainland Australia
Study date
Aug-2008
Auth party contact address
-
Data no
306084
Title
07R/0123-02: Validation of antigens
Study date
18-Nov-2011
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306032
Title
Rare urban-acquired human leptospirosis and environmental health investigation in Sydney, Australia
Study date
19-Feb-2025
Auth party contact address
-
Data no
306055
Title
CoA of starting materials
Study date
30-May-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306104
Title
Batch protocols
Study date
01-Nov-2020
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306061
Title
Australis active constituent
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306116
Title
Serovar Australis replaces serovar Copenhageni as the most common cause of canine leptospirosis in New South Wales, Australia
Study date
Mar-2025
Auth party contact address
-
Data no
306162
Title
LLP 21-48-021 (108218): Duration of immunity study
Study date
01-Apr-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306047
Title
CoA Aluminium cap
Study date
29-May-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306093
Title
SOP TI-5089-0003: Sterility test
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306070
Title
SOP TI-5089-0002: Sterility test by means of direct inoculation
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306133
Title
LEP 18-48-036 (159159): Efficacy of antigen study
Study date
23-May-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306122
Title
A novel tetravalent leptospira bacterin protects against infection and shedding following challenge in dogs
Study date
2012
Auth party contact address
-
Data no
306039
Title
Expert report_Quality
Study date
04-Dec-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
305987
Title
Part 8
Study date
03 Jun 2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306030
Title
Canine Leptospirosis-Do we have a problem?
Study date
2006
Auth party contact address
-
Data no
306179
Title
Canine leptospirosis serological survey
Study date
07-Aug-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306033
Title
Cross-sectional study of canine leptospirosis in animal shelter populations in mainland Australia
Study date
2008
Auth party contact address
-
Data no
306056
Title
07/2025:2262
Study date
2025
Auth party contact address
-
Data no
306176
Title
LE7 21-48-017: Duration of immunity study
Study date
27-Mar-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306050
Title
s8F(1) 92083/134469
Study date
12-Oct-2023
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306067
Title
SOP TI-5139-0005: Internal standards
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306090
Title
SOP TI-5139-0006: Replacement of materials
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306113
Title
Chronic Hepatitis Associated with Leptospiral Infection in Vaccinated Beagles
Study date
1997
Auth party contact address
-
Data no
306165
Title
LEP 13.98.1193: Safety clinical trial study
Study date
23-Jul-2019
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306119
Title
Expert report_Efficacy
Study date
24-Nov-2025
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306130
Title
LE7 21-48-004 (154650): Onset of immunity study
Study date
26-Mar-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306036
Title
Serovar Australis replaces serovar Copenhageni as the most common cause of canine leptospirosis in New South Wales, Australia
Study date
2025
Auth party contact address
-
Data no
306182
Title
Lepto 4 Part 8 Efficacy and Safety (S-0846_2)
Study date
03 Jun 2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306102
Title
COEM-21031: Validation of sterility
Study date
19-Nov-2021
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306110
Title
Vaccination of mice with lipopolysaccharide (LPS) and LPS-derived immuno-conjugates from Leptospira interrogans
Study date
1990
Auth party contact address
-
Data no
306053
Title
Aluminium cap specification
Study date
08-Jul-2010
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306059
Title
Icterohaemorrhagiae active constituent
Study date
2026
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Data no
306159
Title
LLP 24-48-042 (159805): Pilot safety study
Study date
03-Jun-2024
Auth party contact address
Level 1 - Building A, 26 Talavera Road Macquarie Park Australia
Date
Application Date
Application No
Application Number
154536
Product/Active constituent Name
Application Product Name
Brunnings Weed Kill Concentrate
Application Date
Application Number
154536
Application Product Name
Brunnings Weed Kill Concentrate
Application details
Product name:
Brunnings Weed Kill Concentrate
Applicant Name:
BRUNNINGS GARDEN PRODUCTS PTY LTD
Application purpose and description of use:
Registration of a 50 g/L aqueous concentrate of glyphosate to kill weeds and grasses in the home garden.
Date
Application Date
Application No
Application Number
154535
Product/Active constituent Name
Application Product Name
BASF Lexicon Intrinsic Brand Fungicide 02
Application Date
Application Number
154535
Application Product Name
BASF Lexicon Intrinsic Brand Fungicide 02
Application details
Product name:
BASF Lexicon Intrinsic Brand Fungicide 02
Applicant Name:
BASF AUSTRALIA LTD.
Application purpose and description of use:
Registration of a 167.0 g/L FLUXAPYROXAD and 333.0 g/L PYRACLOSTROBIN suspension concentrate (SC) product for use as a broad-spectrum preventative and curative disease treatment for turf.
Date
Application Date
Application No
Application Number
154509
Product/Active constituent Name
Application Product Name
Safari 750 EC Herbicide A
Application Date
Application Number
154509
Application Product Name
Safari 750 EC Herbicide A
Application details
Product name:
Safari 750 EC Herbicide A
Applicant Name:
ADAMA AUSTRALIA PTY LIMITED
Application purpose and description of use:
Registration of a (750 g/L TRICLOPYR PRESENT AS THE BUTOXYETHYL ESTER) SAFARI 750 EC HERBICIDE -A distinguished product name with SAFARI 750 EC HERBICIDE label (APVMA no.83125) name used For the control of a range of woody weeds and melons in Agricultural Non-Crop Areas, Commercial and Industrial Areas, Fallow, Fence Lines, Fire Breaks, Fire Trails, Forests, Pastures, Rights-of-Way, Sorghum and Stubble as per the Directions for Use.
Date
Application Date
Application No
Application Number
154564
Product/Active constituent Name
Application Product Name
Brunnings Glyphosate 360 Weed Kill
Application Date
Application Number
154564
Application Product Name
Brunnings Glyphosate 360 Weed Kill
Application details
Product name:
Brunnings Glyphosate 360 Weed Kill
Applicant Name:
BRUNNINGS GARDEN PRODUCTS PTY LTD
Application purpose and description of use:
Registration of a 360 g/L aqueous concentrate formulation of glyphosate to control weeds and grasses in the home garden and in commercial areas
Date
Application Date
Application No
Application Number
153148
Product/Active constituent Name
Application Product Name
POULVAC CVI VACCINE (SEROTYPE 1, LIVE MAREK'S DISEASE VIRUS)
Application Date
Application Number
153148
Application Product Name
POULVAC CVI VACCINE (SEROTYPE 1, LIVE MAREK'S DISEASE VIRUS)
Application details
Product name:
POULVAC CVI VACCINE (SEROTYPE 1, LIVE MAREK'S DISEASE VIRUS)
Product number:
56670
Applicant Name:
ZOETIS AUSTRALIA PTY LTD
Application purpose and description of use:
Variation of product registration to update the registered sites of manufacture.
Active constituents:
Active constituent name
84664 - MAREK'S DISEASE LIVE VIRUS STRAIN CVI988
Description of data provided:
Data no
304311
Title
CLI
Study date
2026
Auth party contact address
LEVEL 6, 5 RIDER BOULEVARD RHODES Australia
Data no
304312
Title
GMP
Study date
2026
Auth party contact address
-
Data no
304310
Title
GMP
Study date
2026
Auth party contact address
-
Data no
304313
Title
CLI
Study date
2026
Auth party contact address
LEVEL 6, 5 RIDER BOULEVARD RHODES Australia
Date
Application Date
Application No
Application Number
153812
Product/Active constituent Name
Application Product Name
Spirovia 240SC Insecticide B
Application Date
Application Number
153812
Application Product Name
Spirovia 240SC Insecticide B
Application details
Product name:
Spirovia 240SC Insecticide B
Applicant Name:
GROCHEM AUSTRALIA PTY LTD
Application purpose and description of use:
Registration of a 240 g/L suspension concentrate of spirotetramat for the control of various insect pests in cotton and
certain fruit and vegetable crops as per the Directions for Use